Ditchcarbon
  • Contact
  1. Organizations
  2. Merck And Co
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 15 days ago

Merck And Co Sustainability Profile

Company website

Merck & Co., Inc., commonly referred to as Merck, is a leading global healthcare company headquartered in the United States. Founded in 1891, Merck has established itself as a pioneer in the pharmaceutical industry, focusing on innovative medicines, vaccines, and biologic therapies. With a strong presence in North America, Europe, and Asia, the company is dedicated to improving health outcomes worldwide. Merck's core products include groundbreaking treatments in oncology, infectious diseases, and vaccines, notably the HPV vaccine Gardasil and the cancer immunotherapy Keytruda. These offerings are distinguished by their commitment to research and development, which has led to numerous key milestones in medical advancements. As a market leader, Merck consistently ranks among the top pharmaceutical companies globally, recognised for its contributions to public health and its robust pipeline of future therapies.

DitchCarbon Score

How does Merck And Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

96

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Merck And Co's score of 96 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.

97%

Let us know if this data was useful to you

Merck And Co's reported carbon emissions

In 2024, Merck & Co., headquartered in the US, reported total greenhouse gas (GHG) emissions of approximately 1,256,000,000 kg CO2e. This figure includes 146,000,000 kg CO2e from Scope 1 emissions, 100,000,000 kg CO2e from Scope 2 emissions, and a significant 1,110,000,000 kg CO2e from Scope 3 emissions. Merck has set ambitious climate commitments, aiming to reduce its operational GHG emissions (Scopes 1 and 2) by 46% by 2030, using a 2019 baseline. Additionally, the company is targeting a 30% reduction in its Scope 3 emissions within the same timeframe. These targets are aligned with the Science Based Targets initiative (SBTi) and reflect a commitment to achieving net-zero emissions across all scopes by 2045. The company has also pledged to achieve carbon neutrality for its operational emissions (Scopes 1 and 2) by 2025. This commitment underscores Merck's proactive approach to addressing climate change and reducing its carbon footprint in the pharmaceutical sector.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20142015201620172018201920202021202220232024
Scope 1
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
1,532,400,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
5,760,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

How Carbon Intensive is Merck And Co's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Merck And Co's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Merck And Co's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Merck And Co is in US, which has a low grid carbon intensity relative to other regions.

Merck And Co's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Merck And Co has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Merck And Co's Emissions with Industry Peers

Abbvie

US
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Piramal Enterprises Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated 19 days ago

Procter And Gamble

US
•
Chemicals nec
Updated 12 days ago

Novartis Pharmaceuticals Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Frequently Asked Questions

Common questions about Merck And Co's sustainability data and climate commitments

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251120.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy